Search Within

Dean Bajorin

Formats
  1. Journal Article (343)
  2. Meeting Abstract (283)
  3. Book Section (17)
  4. Correspondence (6)
  5. Conference Paper (5)
  6. Review (3)
  7. Book Whole (1)
  8. Editorial (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (660)
  2. Genitourinary Oncology Service (660)
  3. Solid Tumor Oncology Division (660)
  4. Surgery (281)
  5. Urology (271)
  6. Survivorship Research (231)

More Groups

People
  1. Jonathan Rosenberg (204)
  2. Gopakumar Iyer (163)
  3. Hikmat Al-Ahmadie (148)
  4. George Bosl (147)
  5. Bernard Bochner (139)
  6. David Solit (129)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (17)
  4. 2022 (29)
  5. 2021 (32)
  6. 2020 (36)

More Years

Publications
  1. Journal of Clinical Oncology (270)
  2. Annals of Oncology (27)
  3. Cancer (26)
  4. Journal of Urology (25)
  5. Modern Pathology (19)
  6. Laboratory Investigation (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (280)
  2. Elsevier Science, Inc. (58)
  3. Elsevier Inc. (50)
  4. American Association for Cancer Research (40)
  5. Wiley Blackwell (40)
  6. Oxford University Press (35)

More Publishers

Results (660)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post hoc pooled analysis of first-line (1L) pembrolizumab (pembro) for advanced urothelial carcinoma (UC): Outcomes by response at week nine in KEYNOTE-052 and KEYNOTE-361
    Meeting Abstract

    Powles, T.; Alva, A. S.; Ozguroglu, M.; O'Donnell, P. H.; Loriot, Y.; Csoszi, T.; Vuky, J.; Morales-Barrera, R.; Plimack, E. R.; Matsubara, N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • BAYOU: A phase II, randomized, multicenter, double-blind, study of durvalumab (D) in combination with olaparib (O) for the first-line treatment of platinum-ineligible patients with unresectable, stage IV urothelial carcinoma (UC)
    Meeting Abstract

    Rosenberg, J. E.; Park, S. H.; Dao, T. V.; Castellano, D. E.; Li, J. R.; Mukherjee, S.; Howells, K.; Dry, H.; Lanasa, M. C.; Stewart, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Favorable toxicity of chemoradiation for muscle-invasive bladder cancer in elderly, frail patients
    Meeting Abstract

    Moore, A.; Zhang, Z.; Bochner, B. H.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Funt, S. A.; Bajorin, D. F.; Teo, M. Y.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Impact of primary tumor location on efficacy and safety of pembrolizumab (pembro) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) enrolled in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-045 trials
    Meeting Abstract

    O'Donnell, P. H.; Balar, A. V.; Castellano, D. E.; De Wit, R.; Vaughn, D. J.; Powles, T.; Vuky, J.; Lee, J. L.; Fradet, Y.; Bellmunt, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Analysis of disease-free survival in CheckMate 274 by PD-L1 combined positive score and tumor proportion score
    Meeting Abstract

    Galsky, M. D.; Bajorin, D. F.; Witjes, J. A.; Gschwend, J. E.; Tomita, Y.; Nasroulah, F.; Li, J.; Collette, S.; PeĢrez-Valderrama, B.; Grimm, M. O.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
    Journal Article

    Holm, J. S.; Funt, S. A.; Borch, A.; Munk, K. K.; Bjerregaard, A. M.; Reading, J. L.; Maher, C.; Regazzi, A.; Wong, P.; Al-Ahmadie, H.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial
    Journal Article

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H.; Quinlan, C.; Teo, M. Y.; Lee, C. H.; Aggen, D.; Zimmerman, D.; McHugh, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy
    Journal Article

    Almassi, N.; Vertosick, E. A.; Sjoberg, D. D.; Wong, N. C.; Huang, C.; Pietzak, E. J.; Cha, E. K.; Donahue, T. F.; Dalbagni, G.; Bochner, B. H.; more...
    BJU International (2022)

    Fulltext@MSK | Save
  • Infigratinib in early-line and salvage therapy for FGFR3-altered metastatic urothelial carcinoma
    Journal Article

    Lyou, Y.; Rosenberg, J. E.; Hoffman-Censits, J.; Quinn, D. I.; Petrylak, D.; Galsky, M.; Vaishampayan, U.; De Giorgi, U.; Gupta, S.; Burris, H.; more...
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Multiple primary cancers in patients undergoing tumor-normal sequencing define novel associations
    Journal Article

    Liu, Y. L.; Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Tkachuk, K.; Kemel, Y.; Maio, A.; Belhadj, S.; Carlo, M. I.; Latham, A.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save